FDA tells White House to scale back plans to offer boost shots
FDA wants more time to review data
The New York Times reports that officials have told the White House to scale back plans to offer covid booster shots to the general public by Sept 20.
The FDA warned it might only recommend boosters for Pfizer vaccine recipients and possibly only some of them to start. On Moderna, the report says this:
Among the reasons for delaying is that regulators need more time to
decide the proper dosage for a possible third Moderna shot. The
company’s application asking the F.D.A. to authorize a booster shot
contains insufficient data, one federal official familiar with the
process said.
The FDA hasn’t received the raw data from Israel, which is already delivering third doses to everyone.
